Systematic Review Background: Cochleotoxicity following the treatment with platinum-based chemotherapy is well documented. The potential for. Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of. This expert-led course provides an overview of pharmacology in cancer therapy.
|Published:||4 January 2016|
|PDF File Size:||36.27 Mb|
|ePub File Size:||17.50 Mb|
Save for later Description Cancer Pharmacology and Pharmacotherapy Reviewis the first book devoted entirely to providing the "must-know" facts on each cancer agent, including their pharmacokinetics, FDA-approved indications,toxicity, interactions, and other important information that is oncology pharmacology found on oncology pharmacology examinations and essential for any clinician or practitioner to review.
oncology pharmacology Cancer treatment is an area of medicine oncology pharmacology the concepts of multi-modality, drug delivery, and personalized medicine are the most advanced. Therefore, Pharmacology of Anti-Cancer Drugs will also have a particular interest in the following issues: The synergy between chemotherapy and other anticancer modalities, including radio- immuno- and gene therapy; the use of nanoscale particles or targeting moieties to improve drug bioavailability; and the identification of biomarkers derived from proteomics, and genomics oncology pharmacology imaging technologies to predict response or resistance to drug treatment.
Choosing to partner with a company that has access to the best technologies and methods for your needs can allow you to make better decisions, saving you time and money.
oncology pharmacology Cell Line Models At MI Bioresearch, our oncology pharmacology work collaboratively with you to thoroughly evaluate your drug candidates, planning an approach that takes advantage of the widest breadth of analysis tools and models in the industry. Tumor Line Bank We have an extensive tumor line bank, including both human and syngeneic murine models, representing more than 30 distinct histotypes for your research needs.
oncology pharmacology Many models have been characterized for important genetic and molecular markers, and several of these lines have been luciferase-enabled to support in vivo monitoring and tracking by bioluminescence imaging. We are continually expanding our bank of models, the genetic and phenotypic profile of those models, and their use in the subcutaneous, orthotopic, metastatic, and disseminated settings.
The regulation of tyrosine kinases, processing oncology pharmacology proto-oncogenes, regulation of small GTPases and their oncology pharmacology, cell-cycle-specific kinases and DNA repair gene products are being studied as potential targets or to enhance the efficacy of existing chemotherapeutic agents.